The search for meaning—Symptoms and transvaginal sonography screening for ovarian cancer

作者: Edward J. Pavlik , Brook A. Saunders , Stacey Doran , Katherine W. McHugh , Frederick R. Ueland

DOI: 10.1002/CNCR.24407

关键词:

摘要: BACKGROUND: The mortality rate of ovarian cancer is greater than that all other major gynecologic malignancies. Detecting at an early and curable stage long has been objective oncologists. Recently, it was reported certain symptom patterns are informative for the presence malignancy. In this article, authors report on how symptoms ultrasound predict malignancy. METHODS: Two hundred seventy-two women who were participating in annual transvaginal sonography (TVS) screening selected from among 31,748 enrolled. Symptom results correlated with surgical pathology findings. RESULTS: TVS performed better analysis detecting malignancies (sensitivity, 73.3% vs 20%), distinguishing benign tumors (specificity, 91.3% 74.4%). The use TVS series resulted poorer identification malignancy 16.7%) but improved ability to distinguish 97.9%). Decisions using either or combined parallel had small increases sensitivity (+3.3%) coordinated, decreases specificity (−5.8%). CONCLUSIONS: Symptoms did identify malignancies, not as well TVS. current findings indicated that: 1) negative by both a index likely be >97%), 2) adding information weight equal only slightly improves discrimination (sensitivity increase, +3.3%). Thus, benefit discriminating achieved through ultrasound, whereas absence conjunction abnormal (characterized low morphology index) mass surgery may required. Finally, can expected absent 80% patients Cancer 2009. © 2009 American Society.

参考文章(38)
Barbara A. Goff, Lynn Mandel, Howard G. Muntz, Cindy H. Melancon, Ovarian carcinoma diagnosis Cancer. ,vol. 89, pp. 2068- 2075 ,(2000) , 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z
Barbara A. Goff, Lynn S. Mandel, Charles W. Drescher, Nicole Urban, Shirley Gough, Kristi M. Schurman, Joshua Patras, Barry S. Mahony, M. Robyn Andersen, Development of an ovarian cancer symptom index Cancer. ,vol. 109, pp. 221- 227 ,(2007) , 10.1002/CNCR.22371
I E Timor-Tritsch, C Westhoff, W B Warren, A M Sassone, A Artner, Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstetrics & Gynecology. ,vol. 78, pp. 70- 76 ,(1991)
Shigemi Sato, Yoshihito Yokoyama, Tomomi Sakamoto, Masayuki Futagami, Yoshiharu Saito, Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. Cancer. ,vol. 89, pp. 582- 588 ,(2000) , 10.1002/1097-0142(20000801)89:3<582::AID-CNCR13>3.0.CO;2-#
T H Bourne, S Campbell, K M Reynolds, M I Whitehead, J Hampson, P Royston, T J Crayford, W P Collins, Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ. ,vol. 306, pp. 1025- 1029 ,(1993) , 10.1136/BMJ.306.6884.1025
Fred R. Ueland, Paul D. DePriest, Christopher P. DeSimone, Edward J. Pavlik, Subodh M. Lele, Richard J. Kryscio, J.R. van Nagell, The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size Gynecologic Oncology. ,vol. 99, pp. 400- 403 ,(2005) , 10.1016/J.YGYNO.2005.06.030
John R. van Nagell, Paul D. DePriest, Frederick R. Ueland, Christopher P. DeSimone, Amy L. Cooper, J. Matt McDonald, Edward J. Pavlik, Richard J. Kryscio, Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer. ,vol. 109, pp. 1887- 1896 ,(2007) , 10.1002/CNCR.22594
J.R. van Nagell, P.D. DePriest, M.B. Reedy, H.H. Gallion, F.R. Ueland, E.J. Pavlik, R.J. Kryscio, The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecologic Oncology. ,vol. 77, pp. 350- 356 ,(2000) , 10.1006/GYNO.2000.5816
Leniaud Louis, Sifer Christophe, Amy Cooper, David Nelson, Stacy Doran, Fred Ueland, Christopher DeSimone, Paul DePriest, John McDonald, Brook Saunders, Rachel Ware, Edward Pavlik, Richard Kryscio, Michael Karpf, John van Nagell, Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer Current Women's Health Reviews. ,vol. 5, pp. 44- 50 ,(2009) , 10.2174/157340409787721294